With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
Verywell Health on MSN5mon
What to Know About GDMT Heart Failure Medication
Additional medications, known as the pillars of heart ... someone with a new diagnosis of heart failure may start on a low dose of ARNI and beta-blocker, and within a few days or weeks, add ...
Hosted on MSN3mon
A common heart failure medication may help prevent heart damage related to chemotherapy
The SARAH clinical trial examined the effects of the heart-failure medication sacubitril-valsartan, an angiotensin receptor neprilysin inhibitor or ARNI, on preventing further heart damage among ...
The Cardiology Advisor1d
BMI Association With Outcomes for Myocardial Infarction in Heart Failure Unclear
In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.